Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Effect of hormonal contraceptive methods on HIV disease progression: a systematic review.

Phillips SJ, Curtis KM, Polis CB.

AIDS. 2013 Mar 13;27(5):787-94. doi: 10.1097/QAD.0b013e32835bb672. Review.

PMID:
23135169
2.

Copper containing intra-uterine devices versus depot progestogens for contraception.

Hofmeyr GJ, Singata M, Lawrie TA.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD007043. doi: 10.1002/14651858.CD007043.pub2. Review.

PMID:
20556773
3.

Hormonal contraceptive use and risk of HIV-1 disease progression.

Heffron R, Mugo N, Ngure K, Celum C, Donnell D, Were E, Rees H, Kiarie J, Baeten JM; Partners in Prevention HSVHIV Transmission Study Team.

AIDS. 2013 Jan 14;27(2):261-7. doi: 10.1097/QAD.0b013e32835ad473.

4.

Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness.

Whiteman MK, Jeng G, Samarina A, Akatova N, Martirosyan M, Kissin DM, Curtis KM, Marchbanks PA, Hillis SD, Mandel MG, Jamieson DJ.

Contraception. 2016 Jan;93(1):17-24. doi: 10.1016/j.contraception.2015.07.003. Epub 2015 Jul 18.

5.

Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review.

Culwell KR, Curtis KM, del Carmen Cravioto M.

Obstet Gynecol. 2009 Aug;114(2 Pt 1):341-53. doi: 10.1097/AOG.0b013e3181ae9c64. Review.

PMID:
19622996
6.

HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial.

Stringer EM, Levy J, Sinkala M, Chi BH, Matongo I, Chintu N, Stringer JS.

AIDS. 2009 Jul 17;23(11):1377-82. doi: 10.1097/QAD.0b013e32832cbca8.

7.

Hormonal contraception does not increase women's HIV acquisition risk in Zambian discordant couples, 1994-2012.

Wall KM, Kilembe W, Vwalika B, Htee Khu N, Brill I, Chomba E, Johnson BA, Haddad L, Tichacek A, Allen S.

Contraception. 2015 Jun;91(6):480-7. doi: 10.1016/j.contraception.2015.02.004. Epub 2015 Feb 21.

8.

A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus.

Stringer EM, Kaseba C, Levy J, Sinkala M, Goldenberg RL, Chi BH, Matongo I, Vermund SH, Mwanahamuntu M, Stringer JS.

Am J Obstet Gynecol. 2007 Aug;197(2):144.e1-8.

9.

Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy.

Robinson JA, Jamshidi R, Burke AE.

Infect Dis Obstet Gynecol. 2012;2012:890160. doi: 10.1155/2012/890160. Epub 2012 Aug 14. Review.

10.

Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.

Truitt ST, Fraser AB, Grimes DA, Gallo MF, Schulz KF.

Cochrane Database Syst Rev. 2003;(2):CD003988. Review.

PMID:
12804497
11.

Contraception for individuals with sickle cell disease: a systematic review of the literature.

Haddad LB, Curtis KM, Legardy-Williams JK, Cwiak C, Jamieson DJ.

Contraception. 2012 Jun;85(6):527-37. doi: 10.1016/j.contraception.2011.10.008. Epub 2011 Dec 5. Review.

PMID:
22152587
13.

Effect of hormonal contraceptive use on plasma HIV-1-RNA levels among HIV-infected women.

Cejtin HE, Jacobson L, Springer G, Watts DH, Levine A, Greenblatt R, Anastos K, Minkoff HL, Massad LS, Schmidt JB.

AIDS. 2003 Jul 25;17(11):1702-4.

PMID:
12853757
14.

Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review.

Curtis KM, Nanda K, Kapp N.

AIDS. 2009 Nov;23 Suppl 1:S55-67. doi: 10.1097/01.aids.0000363778.58203.b6. Review.

PMID:
20081389
15.

Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy.

Chu JH, Gange SJ, Anastos K, Minkoff H, Cejtin H, Bacon M, Levine A, Greenblatt RM.

Am J Epidemiol. 2005 May 1;161(9):881-90.

PMID:
15840621
16.

Immediate start of hormonal contraceptives for contraception.

Lopez LM, Newmann SJ, Grimes DA, Nanda K, Schulz KF.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD006260. doi: 10.1002/14651858.CD006260.pub3. Review.

PMID:
23235628
17.

Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence.

Polis CB, Curtis KM.

Lancet Infect Dis. 2013 Sep;13(9):797-808. doi: 10.1016/S1473-3099(13)70155-5. Epub 2013 Jul 19. Review.

PMID:
23871397
18.

Contraceptive options for HIV-positive women: making evidence-based, patient-centred decisions.

Sharma M, Walmsley SL.

HIV Med. 2015 Jul;16(6):329-36. doi: 10.1111/hiv.12221. Epub 2015 Feb 17. Review.

19.

Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.

Siegfried N, Uthman OA, Rutherford GW.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008272. doi: 10.1002/14651858.CD008272.pub2. Review.

PMID:
20238364
20.

Highly effective contraception and acquisition of HIV and other sexually transmitted infections.

Morrison CS, Turner AN, Jones LB.

Best Pract Res Clin Obstet Gynaecol. 2009 Apr;23(2):263-84. doi: 10.1016/j.bpobgyn.2008.11.004. Epub 2009 Feb 10. Review.

PMID:
19211309

Supplemental Content

Support Center